Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate vs Propranolol in Migraine
NCT06485726Phase 4Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Jan 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in migraine comparing Valproate Arm with Propranolol Group (2 arms). Primary endpoint: Change in migraine days per 28 days. Started Jan 2023; status: recruiting.
02
Drugs
valproic acidpropranolol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06485726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06485726.